Chemotherapy-induced cardiotoxicity
Showing 1 - 25 of >10,000
Chemotherapy-induced Cardiotoxicity.
Recruiting
- Cardiotoxicity
- +2 more
- Blood sampling
- +4 more
-
Prague, Czechia
- +1 more
Aug 15, 2023
Chemo-induced Cardiotoxicity, Breast Cancer Trial in Tanta (Rosuvastatin 20mg)
Recruiting
- Chemotherapy-induced Cardiotoxicity
- Breast Cancer
- Rosuvastatin 20mg
-
Tanta, EgyptThe Department of Clinical Oncology, Tanta University Hospital
Apr 18, 2022
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Rochester (Echocardiography, Electronic Health Record
Suspended
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Echocardiography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 10, 2023
Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)
Not yet recruiting
- Cardiotoxicity
- +3 more
- Spironolactone
- Placebo
-
São Paulo, BrazilInstituto do Coração
Aug 16, 2023
Serial PET MPI in Patients Undergoing Cancer Treatment
Enrolling by invitation
- Cancer
- +3 more
-
Los Angeles, CaliforniaWest Los Angeles VA Medical Center
Jun 12, 2023
Cardiotoxicity, Acute Myeloid Leukemia in Children, Bone Tumor Trial in Cairo (Capoten®)
Recruiting
- Cardiotoxicity
- +2 more
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357 Cairo, Egypt
Aug 2, 2021
Cardiotoxicity, Cardiac Rehabilitation Trial in Santiago de Compostela (Cardiac rehabilitation)
Active, not recruiting
- Cardiotoxicity
- Cardiac Rehabilitation
- Cardiac rehabilitation
-
Santiago de Compostela, A Coruña, SpainHospital Clínico Universitario de Santiago
May 8, 2021
Cardiomyopathies, Chemo Effect, Diastolic Dysfunction Trial in Tehran (Bisoprolol, Placebo)
Completed
- Cardiomyopathies
- +3 more
- Bisoprolol
- Placebo
-
Tehran, Iran, Islamic Republic ofRasool Akram hospital
Dec 30, 2021
Heart Failure Trial in Ottawa (L-carnitine)
Terminated
- Heart Failure
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Aug 12, 2022
Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)
Recruiting
- Breast Cancer
- Non Hodgkin Lymphoma
-
Middlesbrough, Teesside, United KingdomSouth Tees Hospitals NHS FT
Oct 20, 2022
Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)
Enrolling by invitation
- Breast Cancer
- +4 more
- Silymarin
- Placebo
-
Tanta, EgyptTanta university
Oct 22, 2022
Detection of Chemotherapy Induced Cardiotoxicity
Completed
- Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
- cardiac MRI with DWI
-
Harrison, New York
- +1 more
Sep 3, 2020
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Tumors Trial in San Diego (low dose CT)
Completed
- Neoplasms
- low dose CT
-
San Diego, CaliforniaUniversity of California San Diego Medical Center
Nov 1, 2022
Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)
Not yet recruiting
- Breast Cancer Stage 2 and 3
- Fenofibrate
- +3 more
- (no location specified)
Nov 24, 2023
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer
Recruiting
- Anthracycline Induced Cardiotoxicity
-
Belfast, United KingdomBelfast Health and Social Care Trust
Sep 7, 2022
Breast Cancer, Doxorubicin Induced Cardiotoxicity Trial in Damanhur (Placebo, Montelukast)
Recruiting
- Breast Cancer
- Doxorubicin Induced Cardiotoxicity
- Placebo
- Montelukast
-
Damanhūr, Elbehairah, EgyptDamanhour Oncology Center
Jul 16, 2023
Thoracic Cancer, Left Sided Breast Cancer Trial in Dallas ([1-13C]pyruvate along with MRI imaging)
Suspended
- Thoracic Cancer
- Left Sided Breast Cancer
- [1-13C]pyruvate along with MRI imaging
-
Dallas, TexasDepartment of Radiation Oncology; UT Southwestern Medical Center
Nov 14, 2022
Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Cardiotoxicity Trial in Rozzano (Nebivolol, Placebo)
Active, not recruiting
- Breast Cancer
- +4 more
- Nebivolol
- Placebo
-
Rozzano, Milan, ItalyIRCCS Humanitas Research Hospital
Feb 5, 2023
Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001
Recruiting
- Cancer
- +4 more
- Control group:DH001 placebo
- +2 more
-
Harbin, Heilongjiang, ChinaHarbin Institute of Hematology and Cancer
Oct 20, 2023
Breast Cancer, Myocardial Damage, Cardiotoxicity Trial in Dusseldorf (Cardiac MRI and echocardiography, laboratory parameters)
Completed
- Breast Cancer
- +2 more
- Cardiac MRI and echocardiography, laboratory parameters
-
Dusseldorf, GermanyDivision of Cardiology, Pulmonary Disease and Vascular Medicine
May 19, 2022
Fibrosis in Chronic and Delayed Myocardial Infarction
Recruiting
- Aortic Stenosis
- +2 more
- 68Ga-FAPI and 18F-AlF-FAPI PET-MR
-
Edinburgh, Scotland, United KingdomUniversity of Edinburgh
Mar 1, 2023
Breast Cancer, Doxorubicin Induced Cardiomyopathy Trial in Ottawa (99mTc-rhAnnexin V-128)
Terminated
- Breast Cancer
- Doxorubicin Induced Cardiomyopathy
- 99mTc-rhAnnexin V-128
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Nov 17, 2020
Early Detection of Anthracycline-induced Cardiotoxicity in
Not yet recruiting
- Cardiotoxicity
- +2 more
- (no location specified)
Mar 17, 2022
TRPC6 to Predict and Prevent Chemotherapy Related Cardiac
Not yet recruiting
- Breast Carcinoma
- Cardiotoxicity
- Biospecimen Collection
- Electronic Medical Record
-
Jacksonville, FloridaMayo Clinic in Florida
Aug 17, 2022